section name header
Index
20 Mcg Versus over 20 Mcg Estrogen Combined Oral Contraceptives for Contraception
Administration
Air Travel and Prevention of Venous Thromboembolism by Medication
Anticoagulants Versus Nsaids or Placebo for Venous Thromboembolism
Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for Thrombosis Prophylaxis in Cancer Patients with Central Venous Catheters
Antiplatelet and Anticoagulation for Patients with Prosthetic Heart Valves
Antithrombotic Agents in Primary Health Care - Related Resources
Aortic Aneurysm and Dissection - Related Resources
Aromatase Inhibitors Vs. Tamoxifen in Postmenopausal Women with Early Breast Cancer
ASA for Hypertension
Cardiology
Clinical Value of Simple Proximal Vein Ultrasonography Plus D-Dimer Vs Whole-Leg Colour Doppler Ultrasonography for the Diagnosis of Deep Vein Thrombosis
Cochrane review
Combined Aspirin-Oral Anticoagulant Therapy Compared with Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
Combined Intermittent Pneumatic Compression and Pharmacological Prophylaxis for Prevention of Venous Thromboembolism
Computerized Advice on Drug Dosage to Improve Prescribing Practice
Continuous or Extended Cycle Use of Combined Oral Contraceptives
Dabigatran Versus Lmwhs for Thromboprophylaxis after Total Hip or Knee Replacement
D-Dimer Testing and Pulmonary Embolism
Deep Vein Thrombosis - Related Resources
Duration of Anticoagulant Therapy in Venous Thromboembolism
Duration of Prophylaxis Against Venous Thromboembolism after Surgery for Cancer
Endocrinology
Evidence summary
Extended DVT Prophylaxis after Hospital Discharge in Patients with Elective Hip Arthroplasty
Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for First Episode of Venous Thromboembolism Vs Fatal Bleeding during Continued Anticoagulation
Female
Fondaparinux in the Prevention of Venous Thromboembolism after Surgery
Graduated Compression Stockings in the Prevention of Postoperative Venous Thromboembolism
Gynaecology
Haematology
Heparin for the Prevention of Venous Thromboembolism in General Medical Patients (Excluding Stroke and Myocardial Infarction)
Home Versus in-Patient Treatment for Deep Vein Thrombosis
Hormonal Contraception in Overweight or Obese Women
Hormonal Contraception - Related Resources
Hormone Replacement Therapy and Risk of Venous Thromboembolism
Hormone Therapy for Preventing Cardiovascular Disease in Post-Menopausal Women
Internal medicine
Interventions for Increasing the Use of Thromboprophylaxis in Hospitalized Patients
Interventions for Preventing Venous Thromboembolism Following Abdominal Aortic Surgery
Interventions for Preventing Venous Thromboembolism in Adults Undergoing Knee Arthroscopy
Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives
Long Term Hormone Therapy for Perimenopausal and Postmenopausal Women for Chronic Conditions
Long Versus Short Duration of Anticoagulant Therapy after a First Episode of Venous Thromboembolism
Low-Intensity Warfarin for Long-Term Prevention of Venous Thromboembolism
Low-Molecular Weight Heparin in Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy
Low Molecular Weight Heparin in Patients with Lower-Leg Immobilization
Low-Molecular-Weight Heparins (Lmwh) Versus Unfractionated Heparin for Venous Thromboembolism
Low-Molecular-Weight Heparins Vs. Standard Heparin for Acute Ischaemic Stroke
Lung Cancer - Related Resources
Melphalan and Prednisolone Plus Thalidomide Compared to other Treatments for Multiple Myeloma in the Elderly
Menopausal Hormone Therapy and Breast Cancer
Neurosurgery
Obstetrics
Once Daily Vs Twice Daily Low Molecular Weight Heparin (Lmwh) for Deep Vein Thrombosis
Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism
Oncology
Optimal Loading Dose of Warfarin for the Initiation of Oral Anticoagulation
Oral Contraceptives in Patients Who have Experienced One Venous Thrombosis
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Deep Vein Thrombosis
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Orthopaedics
Parenteral Anticoagulation in Ambulatory Patients with Cancer
Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Prevention of Venous Thromboembolism
Prevention of Venous Thromboembolism - Related Resources
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
Prolonged Thromboprophylaxis with Low Molecular Weight Heparin for Abdominal or Pelvic Surgery
Prothrombin Complex Concentrate for Reversal of Vitamin K Antagonist Treatment
Pulmonary Embolism
Raloxifene for the Prevention of Fractures in Postmenopausal Women
Recurrent Miscarriage - Related Resources
Risk for Heparin-Induced Thrombocytopenia (HIT) with Either Low-Molecular-Weight Heparin (Lmwh) or Unfractionated Heparin (Ufh)
Risk of a Venous Thromboembolism during the Postpartum Period
Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives
Risk of Venous Thromboembolism with the Use of Oral Contraceptives
Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Safety of Ruling out Acute Pulmonary Embolism in Outpatients by Normal Computed Tomography Pulmonary Angiography
Self-Monitoring and Self-Management of Oral Anticoagulation
Statins for Primary Prevention of Venous Thromboembolism
Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism
Surgery Versus Thrombolysis for Initial Management of Acute Limb Ischaemia
Surgery
Systematic review
Testing for Cancer in Patients with Unprovoked Venous Thromboembolism
Third Generation Oral Contraceptives and Risk of Venous Thromboembolism
Tranexamic Acid for Preventing Postpartum Haemorrhage
Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke
Transfusion Thresholds for Guiding Allogeneic Red Blood Cell Transfusion
Treatment for Superficial Thrombophlebitis of the Leg
Treatment of Distal Deep Vein Thrombosis
Vascular surgery
Vitamin K Antagonists or Low-Molecular Weight Heparin for Venous Thromboembolism
Warfarin Therapy - Related Resources